1 documents found
Information × Registration Number 0105U003279, R & D request Title Clinical trial known as "A Phase III multinational, multi-centre, double-blind placebo-controlled parallel group, 26 week study to assess the maintenance of clinical responce to humanized anti-TNF PEG conjugate, CDP870 400 mg sc, (dosed 4-weekly from weeks 8 to 24), in the treatment of patients with active Crohn's disease who have responded to open induction therapy (dosed at weeks 0,2 and 4) with CDP870 Head Захараш Михайло Петрович, Registration Date 14-05-2005 Organization Bogomolets National Medical University, Ministry of Health of Ukraine popup.description1 popup.nrat_date 2024-12-11 Close
search.res_rk
Clinical trial known as "A Phase III multinational, multi-centre, double-blind placebo-controlled parallel group, 26 week study to assess the maintenance of clinical responce to humanized anti-TNF PEG conjugate, CDP870 400 mg sc, (dosed 4-weekly from weeks 8 to 24), in the treatment of patients with active Crohn's disease who have responded to open induction therapy (dosed at weeks 0,2 and 4) with CDP870
Head: Захараш Михайло Петрович. Clinical trial known as "A Phase III multinational, multi-centre, double-blind placebo-controlled parallel group, 26 week study to assess the maintenance of clinical responce to humanized anti-TNF PEG conjugate, CDP870 400 mg sc, (dosed 4-weekly from weeks 8 to 24), in the treatment of patients with active Crohn's disease who have responded to open induction therapy (dosed at weeks 0,2 and 4) with CDP870. Bogomolets National Medical University, Ministry of Health of Ukraine. № 0105U003279
1 documents found

Updated: 2026-03-25


Роздрукувати цю сторінку